NCT01642966View on ClinicalTrials.gov

Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Prasugrel

Prasugrel 10mg/day for 15 days

DRUG

Ticagrelor

Ticagrelor 90mg twice a day for 15 days

Trial Locations (1)

26500

Cardiology Department Patras University Hospital, Pátrai

All Listed Sponsors
lead

University of Patras

OTHER

NCT01642966 - Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter